Reterospective study of Blinatumomab in patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Latest Information Update: 15 Jan 2019
At a glance
- Drugs Blinatumomab (Primary) ; Dasatinib; Nilotinib; Ponatinib
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 15 Jan 2019 New trial record
- 04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology